Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.79 USD | -1.07% | +8.47% | -31.16% |
Financials (USD)
Sales 2024 * | 360M | Sales 2025 * | 249M | Capitalization | 5.2B |
---|---|---|---|---|---|
Net income 2024 * | -513M | Net income 2025 * | -527M | EV / Sales 2024 * | 18 x |
Net Debt 2024 * | 1.29B | Net Debt 2025 * | 1.67B | EV / Sales 2025 * | 27.6 x |
P/E ratio 2024 * |
-9.53
x | P/E ratio 2025 * |
-9.55
x | Employees | 553 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.72% |
Latest transcript on BridgeBio Pharma, Inc.
1 day | -1.07% | ||
1 week | +8.47% | ||
Current month | +8.47% | ||
1 month | -1.10% | ||
3 months | -17.71% | ||
6 months | -5.44% | ||
Current year | -31.16% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 14-12-31 |
Charles Homcy
FOU | Founder | 75 | 14-12-31 |
Founder | 73 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 16-02-29 |
Founder | 73 | 14-12-31 | |
Fred Hassan
BRD | Director/Board Member | 78 | 21-08-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.35% | 2 M€ | -.--% | ||
0.12% | 7 M€ | -.--% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 27.79 | -1.07% | 941,795 |
24-05-06 | 28.09 | +0.93% | 839,493 |
24-05-03 | 27.83 | +0.32% | 1,677,282 |
24-05-02 | 27.74 | +2.63% | 1,201,763 |
24-05-01 | 27.03 | +5.50% | 2,283,562 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.16% | 5.2B | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.40% | 31.87B | |
+53.68% | 24.52B | |
-14.35% | 15.68B | |
-6.52% | 12.34B | |
-39.65% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- BBIO Stock